Table 6.
Cryoprotectant treatment | Embryo development stages | |||
---|---|---|---|---|
Globular | Heart | Torpedo | Cotyledonary | |
Control | 61.5 ± 1.18a | 22.5 ± 1.2a | 9.00 ± 0.80c | 6.25 ± 1.7a |
5% PEG (CP-A) | 54.33 ± 2.27b | 21.11 ± 2.34b | 14.34 ± 1.34a | 6.61 ± 0.89a |
10% PEG (CP-B) | 52.78 ± 1.85c | 19.23 ± 1.67c | 12.55 ± 1.67b | 5.38 ± 1.54b |
Optimized MS medium contained NAA (0.5 mg/l) + BAP (1.5 mg/l). Values are means ± standard errors of 3 replicates of two experiments. Mean values within a column followed by different letters are significantly different at p = 0.05 according to Duncan’s Multiple Range Test (DMRT).